These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation. Pereira CM; de Almeida OP; Corrêa ME; Costa FF; de Souza CA; Barjas-Castro ML Oral Dis; 2007 May; 13(3):329-34. PubMed ID: 17448218 [TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723 [TBL] [Abstract][Full Text] [Related]
10. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Epstein JB; Phillips N; Parry J; Epstein MS; Nevill T; Stevenson-Moore P Bone Marrow Transplant; 2002 Dec; 30(11):785-92. PubMed ID: 12439702 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917 [TBL] [Abstract][Full Text] [Related]
12. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Brand HS; Bots CP; Raber-Durlacher JE Br Dent J; 2009 Nov; 207(9):E17; discussion 428-9. PubMed ID: 19893563 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cell chimerism in oral mucosa of transplanted patients affected by graft-versus-host disease. Pérez CA; Rabanales R; Rojas-Alcayaga G; Larrondo M; Escobar AF; López MN; Salazar-Onfray F; Alfaro JI; González FE J Oral Pathol Med; 2016 Feb; 45(2):127-35. PubMed ID: 26102283 [TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients. Correia-Silva Jde F; Victória JM; Guimarães AL; Salomão UE; de Abreu MH; Bittencourt H; Gomez RS Oral Dis; 2007 Mar; 13(2):163-9. PubMed ID: 17305617 [TBL] [Abstract][Full Text] [Related]
15. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906 [TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604 [TBL] [Abstract][Full Text] [Related]
17. Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study. Bulthuis MS; van Leeuwen SJM; Thomas RZ; van Gennip LLA; Whiteside HM; Isom S; Kline DM; Laheij AMGA; Raber-Durlacher JE; Hasséus B; Johansson JE; Hovan AJ; Brennan MT; von Bültzingslöwen I; Huysmans MDNJM; Blijlevens NMA Transplant Cell Ther; 2024 Apr; 30(4):446.e1-446.e11. PubMed ID: 38242439 [TBL] [Abstract][Full Text] [Related]
18. Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation. Sohn SK; Kim DH; Baek JH; Kim JG; Lee KB; Lee KH; Lee JH; Choi SJ; Lee JH; Shin IH Bone Marrow Transplant; 2006 Apr; 37(7):699-708. PubMed ID: 16501588 [TBL] [Abstract][Full Text] [Related]
19. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991 [TBL] [Abstract][Full Text] [Related]
20. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ; Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]